phrykt

Bluejay Diagnostics, Inc. (BJDX): who owns it and who trades it

As of Nov 16, 2026, BJDX insiders reported 1 open-market sale worth $48.9K and 2 purchases worth $122K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Hrt Financial Lp (10% owner), with $48.9K. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Bluejay Diagnostics

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, BJDX insiders reported $122K of open-market purchases and $48.9K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$122K
2 trades, 2 people
Sales, 12 months
$48.9K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jul 10, 2026
Filed Jul 13, 2026

Purchases and sales by month

$96.7K$96.7KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jul 10, 2026Hrt Financial Lp10% ownerSale34,938$1.40$48.9KForm 4
Jul 9, 2026Hrt Financial Lp10% ownerPurchase64,047$1.51$96.7KForm 4
Mar 14, 2026Douglas Clark WurthDirectorPurchase12,500$2.00$25KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Hrt Financial Lp10% owner$96.7K$48.9KJul 10, 2026
Douglas Clark WurthDirector$25K–Mar 14, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BJDX short interest

Low short interest. 1.7% of BJDX shares are sold short: about 1 share in 57. Over the last 12 reports the number of shares short went up 1053%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 77,889 BJDX shares were sold short, 1.7% of the shares outstanding, down 46.1% from the report before. At the average daily volume of 77,098 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

1.74%May 15Oct 3067.3%

Days to cover

1.0May 15Oct 301.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202677,8891.74%-46%77,0981.0
Oct 15, 2026144,4023.23%+0%706,3731.0
Sep 30, 2026143,7373.22%+9%728,4121.0
Sep 15, 2026131,4822.94%-50%4.78M1.0
Aug 31, 2026265,1155.93%+412%1.25M1.0
Aug 14, 202651,8091.16%+205%11.84M1.0
Jul 31, 202616,9801.75%-97%555,5311.0
Jul 15, 2026569,67558.60%+25%15.38M1.0
Jun 30, 2026455,19746.82%+157%444,3731.0
Jun 15, 2026177,20918.23%+470%6.89M1.0
May 29, 202631,0993.20%+360%125,4061.0
May 15, 20266,7570.70%-69%32,4411.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Bluejay Diagnostics company events

Bluejay Diagnostics filed 19 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026AnnouncementThe Company issued a press release relating to the matters described in Item 5.03 above. Filing
  2. Oct 13, 2026AnnouncementShared information with investors. Filing
  3. Oct 6, 2026AnnouncementShared information with investors. Filing
  4. Sep 8, 2026AgreementBluejay Diagnostics, Inc. entered into a Distribution, Co-Marketing & Strategic Partnership Agreement with Lovell Government Services, Inc., a Service-Disabled Veteran-Owned Small Business specializing in federal healthcare distribution. Filing
  5. Aug 13, 2026AnnouncementShared information with investors. Filing
  6. Jul 22, 2026AnnouncementShared information with investors. Filing
  7. Jun 9, 2026LeadershipBluejay Diagnostics, Inc. held its 2026 annual meeting of stockholders. Filing
  8. Jun 8, 2026AgreementBluejay Diagnostics, Inc., in connection with a private placement of the Company’s securities, entered into with certain institutional, accredited investors (i) a securities purchase agreement, and (ii) a registration rights agreement. Filing
  9. Jun 2, 2026AgreementBluejay Diagnostics, Inc. entered into an agreement and statement of work (together, the “Agreement”) with Argonaut Manufacturing Services c/o Argonaut, Inc. regarding the provision by Argonaut to the Company of certain manufacturing services to support the Company’s Symphony™ platform. Filing
  10. May 7, 2026ResultsReleased financial results. Filing
  11. Apr 7, 2026AnnouncementShared information with investors. Filing
  12. Mar 17, 2026AgreementBluejay Diagnostics, Inc. entered into a securities purchase agreement pursuant to which the Company issued and sold to the purchasers named therein an aggregate of 62,500 shares of the Company’s common stock at a price of $2.00 per share (such transaction, the “Private Placement”). Filing
  13. Mar 16, 2026AnnouncementShared information with investors. Filing
  14. Mar 12, 2026AnnouncementShared information with investors. Filing
  15. Mar 6, 2026ResultsReleased financial results. Filing
  16. Feb 20, 2026AnnouncementShared information with investors. Filing
  17. Feb 18, 2026AnnouncementShared information with investors. Filing
  18. Jan 30, 2026AnnouncementThe Company issued a press release relating to the matters described in Item 5.03 above. Filing
  19. Dec 30, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Bluejay Diagnostics financials

Famous investors that hold BJDX

1 of the 50 well-known investors we track reported holding BJDX in their latest 13F filing. The largest position is Ken Griffin's, worth $46.8K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202654,764$46.8K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named BJDX in the last 120 days.

FiledHolderFormStake
Nov 10, 2026Mitchell P. Kopin13G/A5.0%
Nov 10, 2026Mitchell P. Kopin13G/A5.0%

Questions about Bluejay Diagnostics, Inc. (BJDX) stock

Are BJDX insiders buying or selling?

In the last 12 months, BJDX insiders reported 2 open-market purchases worth $122K and 1 sale worth $48.9K. The latest trade was on Jul 10, 2026. See every trade.

What is the short interest in BJDX?

As of Oct 30, 2026, 77,889 BJDX shares were sold short, 1.7% of the shares outstanding, down 46.1% from the report before. At the average daily volume of 77,098 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold BJDX?

1 of the 50 well-known investors we track reported BJDX in their latest 13F filing, including Ken Griffin. The largest position is worth $46.8K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.